Evidence map›Paper›PMID 35604634›Full record

ArticleDrug delivery and translational research2022

Soluplus

Rosario Pignatello, Roberta Corsaro, Angela Bonaccorso, Elide Zingale, Claudia Carbone, Teresa Musumeci

Abstract read
In one paragraph

Article in Drug delivery and translational research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed.

  1. From prediction to performance:International journal of pharmaceutics: X · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Rosario PignatelloDepartment of Drug and Health Sciences, University of Catania, 95125, Catania, Italy. r.pignatello@unict.it.ORCID http://orcid.org/0000-0002-5937-4192
Roberta CorsaroDepartment of Drug and Health Sciences, University of Catania, 95125, Catania, Italy.
Angela BonaccorsoDepartment of Drug and Health Sciences, University of Catania, 95125, Catania, Italy.
Elide ZingaleDepartment of Drug and Health Sciences, University of Catania, 95125, Catania, Italy.
Claudia CarboneDepartment of Drug and Health Sciences, University of Catania, 95125, Catania, Italy.
Teresa MusumeciDepartment of Drug and Health Sciences, University of Catania, 95125, Catania, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The issue of poor aqueous solubility is often a great hitch in the development of liquid dosage forms for those drugs that the Biopharmaceutics Classification System (BCS) includes in classes II and IV. Among the possible technological solutions, inclusion of the drug molecule within polymeric micelles, and particularly nanomicelles, has been proposed in the last years as a valid strategy. Our attention has been recently attracted by Soluplus

Indexed as

BiopharmaceuticsMicellesPolyethylene GlycolsPolymersPolyvinylsSolubilityMicellesPolyethylene GlycolsPolymerspolyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymerPolyvinylsAqueous solubilityDrug deliveryLogSMicellesNanomedicine

Identifiers

PMID35604634
PMCPMC9242938

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.